Lenvatinib, Pembrolizumab, and Paclitaxel for Treatment of Recurrent Endometrial, Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Paclitaxel
Related studies linked through entity extraction aliases.
MicroRNA Profiles in Triple Negative Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Study to Compare a Mono Atezolizumab Window Followed by a Atezolizumab - CTX Therapy With Atezolizumab - CTX Therapy
- Status
- TERMINATED
- Phase
- PHASE2
Camrelizumab Combined With SRT/WBRT and Chemotherapy in Patients With Brain Metastases of Driven Gene-negative NSCLC
- Status
- COMPLETED
- Phase
- PHASE3
Phase II Study of Postoperative Concurrent Chemoradiotherapy for Esophageal Squamous Cell Carcinoma (ESO- Shanghai 17)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Study of Sequential Systemic Therapy + Intraperitoneal Paclitaxel in Gastric/GEJ Peritoneal Carcinomatosis
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
LCI-BRE-MTN-NIR-001:Ph I Study of Niraparib in Combo With Standard Chemo in Metastatic Trip Neg Breast Cancer
- Status
- WITHDRAWN
- Phase
- PHASE1
First in Human Study of UCT-01-097 in Participants With Advanced Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
Study of Pembrolizumab With Single Agent Chemotherapy in Elderly Patients With Advanced NSCLC
- Status
- WITHDRAWN
- Phase
- PHASE2
Capivasertib China PK Study
- Status
- COMPLETED
- Phase
- PHASE1
Comparison of Standard of Care Treatment With a Triplet Combination of Targeted Immunotherapeutic Agents
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Trial of AK112 (PD1/VEGF Bispecific) in Combination With Chemotherapy in Patients With NSCLC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Study Evaluating Effectiveness and Safety of Zimberelimab and Domvanalimab in Lung Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Batiraxcept (AVB-S6-500)/Placebo in Combination With Paclitaxel in Patients With Platinum-Resistant Recurrent Ovarian Cancer
- Status
- TERMINATED
- Phase
- PHASE3
Alpelisib Plus Olaparib in Platinum-resistant/Refractory, High-grade Serous Ovarian Cancer, With no Germline BRCA Mutation Detected
- Status
- TERMINATED
- Phase
- PHASE3
A Study of Cemiplimab With Chemotherapy and Immunotherapy in People With Head and Neck Cancer
- Status
- RECRUITING
- Phase
- PHASE1
First-in-Human Evaluation of GRN-300 in Subjects With Recurrent Ovarian, Primary Peritoneal, and Fallopian Tube Cancers.
- Status
- SUSPENDED
- Phase
- PHASE1
Trastuzumab Deruxtecan for Subjects With HER2-Positive Gastric Cancer or Gastro-Esophageal Junction Adenocarcinoma After Progression on or After a Trastuzumab-Containing Regimen (DESTINY-Gastric04)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
The Conversion Therapy of Chemotherapy Plus Camrelizumab in Metastatic Gastric Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Propranolol With Standard Chemoradiation for Esophageal Adenocarcinoma
- Status
- RECRUITING
- Phase
- PHASE2